Ticker: STMN.SW

Straumann

Healthcare Healthcare Medical - Instruments & Supplies
Price —
Potential 0 Risk 0 Updated 2026-10-03

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Straumann is a global leader in dental implant and restorative solutions, focusing on innovative products and services for dental professionals. Its core offerings include dental implants, prosthetics, and digital solutions for dental practices. Major business segments encompass implant systems, prosthetic solutions, and digital dentistry, with primary revenue sources derived from sales of dental implants and related products.

Investment Profile

The investment profile of Straumann is more aligned with growth investors, given its focus on innovation and expansion in the dental sector. The company is positioned for potential long-term appreciation, appealing to those seeking capital gains rather than immediate income.

Nothing yet

News Page 1 of 1
Scout24 IMCD Straumann

Analysts Goldman Sachs add Solaria (SLR) and three other companies to their European Conviction List with significant upside potential

Goldman Sachs has updated its European 'Conviction List' by adding four stocks with significant upside potential, highlighting opportunities in renewable energy, dental implants, real estate, and specialty chemicals, while removing three others. This shift reflects the bank's strategic focus on companies poised for growth amid current market conditions.